Welcome to Our Survey

Neovascular (Wet) Age-related Macular Degeneration Patient Survey 


Purpose of the Survey:

You are invited to participate in an online survey which is being conducted in order to better understand patient perception and attitudes to the current care pathway for the treatment of neovascular age-related macular degeneration (nAMD). You may have heard of this referred to as wet AMD. The survey contains 7 sections and will take approximately 22 minutes to complete.

This survey will collect personal information about you including how you manage your treatment for wet AMD, and your perception of your treatment pathway. Your personal experience information will be used to estimate the levels of satisfaction wet AMD patients have with their typical treatment pathway involving eye injections PRIOR TO ANY COVID-19 INTERRUPTION, and to describe the characteristics of groups of people (not individuals) who have wet AMD. 

Confidentiality

Your personal information collected as part of this survey will be kept strictly confidential and your identity will not be revealed. Your information will only be accessed by authorised personnel where required for the purpose of administering the survey and conducting the analysis. Your individual data will be permanently deleted upon completion of this survey.

The legal basis for processing personal information/ Consent form

Before you complete this survey you will be asked to provide your consent to the collection and processing of your personal information. Your consent will then form the legal basis upon which we are able to process your survey responses. 

Voluntary participation/right to refuse or withdraw your information

Your participation in this survey is voluntary; you can withdraw at any time if you change your mind. If you decide to withdraw your consent by exiting the survey mid-way through, your responses will not be recorded. You have the right to seek access to, or to correct, or delete your information.  Your information will not be retained, following analysis of survey responses, your information will be permanently deleted. Please email Orla.Galvin@retina-international.org if you would like to correct or delete any of your information.

By providing consent you are telling us that you: 

  • Understand what you have read. 
  • Are 18 years or over. 
  • Consent to take part in this research project on patient satisfaction.
  • Consent to the processing of your personal information for the purpose described in the introduction to this survey 

Question Title

* Please confirm you have read and understood the information provided. By selecting ‘yes’ you agree to your involvement in the survey to better understand patient perception and attitudes to the care pathway involving eye injections (PRIOR TO ANY COVID-19 INTERRUPTION) for the treatment of wet age-related macular degeneration (wet AMD).

0 of 81 answered
 

T